Cytokines and Growth Factors in the Treatment of Osteoarthritis: What Could be the Best Disease Modifying Drugs

E-ISSN： 1875-6131|4|3|235-249

ISSN： 1568-0142

Source： Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol.4, Iss.3, 2005-06, pp. : 235-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disease Modifying Osteoarthritis Drugs: Facing Development Challenges and Choosing Molecular Targets

Current Drug Targets, Vol. 11, Iss. 5, 2010-05 ,pp. : 528-535

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Pathways and Promising Agents with Possible Disease Modifying Effect in Osteoarthritis Treatment

Current Drug Targets, Vol. 15, Iss. 6, 2014-06 ,pp. : 635-661

Bentham Science Publishers

Access to resources Recommend Favorite

The Mechanisms of Action of Disease-Modifying Antirheumatic Drugs: A Review with Emphasis on Macrophage Signal Transduction and the Induction of Proinflammatory Cytokines

By Bondeson J.

General Pharmacology, Vol. 29, Iss. 2, 1997-08 ,pp. : 127-150

Elsevier

Access to resources Recommend Favorite

An Update on Disease Modifying Antirheumatic Drugs

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 4, 2014-08 ,pp. : 249-261

Bentham Science Publishers

Access to resources Recommend Favorite

Licofelone a likely disease modifying therapy for osteoarthritis

Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite